Trademark: 85982315
Status Date
Friday, September 3, 2021
Registration Number
4679528
Registration Date
Tuesday, January 27, 2015
Filing Date
Wednesday, February 8, 2012
Published for Opposition
Tuesday, November 19, 2013
Cancellation Date
Friday, September 3, 2021
42 Cloud computing for pathology and whole slide imaging featuring software for use in automated acquisition and analysis of images of human and animal cells and tissues, for use in entering, storing and analyzing data, for management of medical diagnostic, prognostic and predictive information by clinicians, research scientists and pathologists and other laboratory professionals in the fields of pathology, oncology, pharmaceutical drug and therapy development and whole slide imaging, data reporting, tissue bank sample management and test results archiving, with data archiving and retrieval features; providing databases in the field of spectral imaging information based on biomarkers for disease detection and treatment for scientific research purposes; providing an on-line searchable database in the field of pathology and the use of biomarkers for disease detection and treatment for scientific research purposes only; clinical laboratory providing biomarker research services; data mining of database featuring patient sample biomarkers; biomarker screening for scientific research purposes; pharmaceutical drug design; pharmaceutical research and development services in the fields of drug design and drug delivery; conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical research and development in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; and companion diagnostics and assays services in the field of gene therapy design and delivery; and laboratory services, namely, archiving tissue and cell samples for use in the field of gene therapy design and delivery for research purposes
44 Providing on-line searchable databases featuring health-related information on spectral results of biomarkers used in the detection and treatment of disease; medical diagnostic reporting, prognostic and predictive reporting; medical services in the fields of cytology, histology and pathology; medical adjunctive and triage testing for diagnostic or treatment purposes; medical prognostic and diagnostic testing in the field of biomarkers for disease detection and treatment; medical screening, monitoring, companion diagnostic testing services; medical services, namely, gene therapy design and delivery services in the fields of oncology, pathology, and biomarkers
Color is not claimed as a feature of the mark.
"THERANOSTICS"
THERAPY DIAGNOSTICS
Sep 3, 2021
Cancelled Sec. 8 (6-Yr)
Jul 5, 2017
Automatic Update Of Assignment Of Ownership
Jan 27, 2015
Registered-Principal Register
Dec 23, 2014
Notice Of Acceptance Of Statement Of Use Mailed
Dec 21, 2014
Allowed Principal Register - Sou Accepted
Dec 10, 2014
Teas/Email Correspondence Entered
Dec 9, 2014
Correspondence Received In Law Office
Dec 9, 2014
Teas Response To Office Action Received
Sep 4, 2014
Non-Final Action Mailed
Sep 4, 2014
Su - Non-Final Action - Written
Aug 14, 2014
Notice Of Pseudo Mark Mailed
Aug 13, 2014
Statement Of Use Processing Complete
Jul 14, 2014
Use Amendment Filed
Aug 13, 2014
Divisional Processing Complete
Jul 14, 2014
Divisional Request Received
Aug 12, 2014
Case Assigned To Intent To Use Paralegal
Jul 14, 2014
Teas Request To Divide Received
Jul 14, 2014
Teas Statement Of Use Received
Jan 14, 2014
Noa Mailed - Sou Required From Applicant
Nov 19, 2013
Published For Opposition
Oct 30, 2013
Notice Of Publication
Oct 15, 2013
Law Office Publication Review Completed
Oct 7, 2013
Approved For Pub - Principal Register
Sep 13, 2013
Examiners Amendment Mailed
Sep 13, 2013
Examiner's Amendment Entered
Sep 13, 2013
Examiners Amendment -Written
Aug 26, 2013
Non-Final Action Mailed
Aug 25, 2013
Non-Final Action Written
Jun 21, 2013
Examiners Amendment Mailed
Jun 20, 2013
Examiner's Amendment Entered
Jun 20, 2013
Examiners Amendment -Written
Dec 31, 2012
Final Refusal Mailed
Dec 29, 2012
Final Refusal Written
Aug 16, 2012
Teas/Email Correspondence Entered
Aug 16, 2012
Correspondence Received In Law Office
Aug 13, 2012
Assigned To Lie
Aug 3, 2012
Teas Response To Office Action Received
May 29, 2012
Non-Final Action Mailed
May 28, 2012
Non-Final Action Written
May 18, 2012
Assigned To Examiner
Feb 14, 2012
Notice Of Pseudo Mark Mailed
Feb 13, 2012
New Application Office Supplied Data Entered In Tram
Feb 11, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
